ACC.18
Dabigatran Cuts Risk of Major CV Complications in Patients With MINS
The primary efficacy outcome was the combined rate of death from a cardiovascular cause, heart attack, stroke due to inadequate blood supply, blood clots or amputation due to cardiovascular disease.
